These 2 Stocks Just Declared Dividend Raises That Kick In Next Year. Should You Buy?

It isn't easy to find steady and reliable dividend payers in the pharmaceutical industry. The key reason is simple: Drug development is a frequently laborious and expensive process that can swallow vast amounts of capital.Yet there is a clutch of companies at the top of the industry not only paying distributions regularly, but also lately increasing them on a consistent basis.Two of these, Bristol Myers Squibb (BMY -1.41%) and Eli Lilly (LLY -1.79%), just declared dividend raises. What's more, since the new ...